Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlpha Real Regulatory News (ARTL)

  • There is currently no data for ARTL

Monk Bridge - Further Planning Consent

4 Oct 2018 16:28

RNS Number : 0435D
Alpha Real Trust Limited
04 October 2018
 

LEI: 213800BMY95CP6CYXK69

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. 

4 October 2018

 

ALPHA REAL TRUST LIMITED ("ART" OR THE "COMPANY") ANNOUNCES FURTHER PLANNING CONSENT GRANTED FOR RESIDENTIAL DEVELOPMENT SITE, "MONK BRIDGE", CENTRAL LEEDS

 

Further to the 17 August 2018 trading update, the Company announces that a further planning consent has been granted at the monthly planning committee for Leeds City Council in respect of the Company's Private Rented Sector ("PRS") development site at Monk Bridge in central Leeds.

Detailed planning consent was originally granted in May 2017 for 307 PRS flats in three buildings over 180,049 square feet of net saleable space and the restoration of the adjacent Grade II listed former railway arches as a raised park and ancillary retail, leisure and restaurant uses over 25,080 square feet in 16 units in the former arches below.

Detailed planning consent has now been granted for a further 357 residential units in two buildings of up to 21 storeys over 208,191 square feet of net saleable space. The Gross Development Value ("GDV") of the combined Monk Bridge scheme is £153 million. The approval includes a provision for 5% of the 664 units as affordable.

The Company is advised that this additional planning consent will result in a material increase in the carrying value of the Monk Bridge asset, which is currently valued in the Company's accounts at £9 million. The updated valuation will be reflected in the Net Asset Value for the period ending 30 September 2018 which is expected to be announced on 16 November 2018. The Company acquired the development site in December 2015 for a price of £3.75 million at which time the site had implemented planning consent for 269 residential units with an estimated GDV of £55 million. The Company is continuing discussions with its contractor, Sir Robert McAlpine, to optimise development costs for the approved scheme.

 

For further information please contact:

Alpha Real Trust Limited

David Jeffreys, Chairman, Alpha Real Trust +44 (0) 1481 231 100

Brad Bauman, Joint Fund Manager, Alpha Real Trust +44 (0) 20 7391 4700

Panmure Gordon, Broker to the Company

Richard Gray / Andrew Potts +44 (0) 20 7886 2500

Registered office: Old Bank Chambers, La Grande Rue, St Martin's, Guernsey, GY4 6RT

Alpha Real Trust Limited is advised by Alpha Real Capital LLP, which is authorised and regulated by the Financial Conduct Authority in the United Kingdom.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBUBDGRDGBGIS
Date   Source Headline
22nd Jan 20252:35 pmRNSTransaction in Own Shares
21st Jan 20252:35 pmRNSShare Buyback
20th Jan 20254:28 pmRNSAcquisition of Crematoria
20th Jan 202510:06 amRNSResult of Tender Offer
20th Dec 202410:18 amRNSResult of Extraordinary General Meeting
17th Dec 20241:53 pmRNSAcquisition of Travelodge hotel in Liverpool, UK
13th Dec 202410:07 amRNSHalf-year Report 2024
6th Dec 20247:00 amRNSDelisting, Tender Offer, New Arts & Notice of EGM
22nd Nov 20247:00 amRNSHalf-year Report
1st Nov 20247:00 amRNSTotal Voting Rights
30th Oct 202411:04 amRNSDirector/PDMR Shareholding
29th Oct 202412:36 pmRNSDirector/PDMR Shareholding
29th Oct 202412:33 pmRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
22nd Oct 20247:00 amRNSResults of Scrip Dividend Alternative Election
13th Sep 20247:00 amRNSTrading Update and Dividend Announcement
5th Sep 20241:31 pmRNSResult of AGM
1st Aug 20247:00 amRNSTotal Voting Rights
30th Jul 20243:10 pmRNSDirector/PDMR Shareholding
30th Jul 20243:09 pmRNSDirector/PDMR Shareholding
30th Jul 20243:08 pmRNSDirector/PDMR Shareholding
30th Jul 20242:27 pmRNSDirector/PDMR Shareholding
23rd Jul 20247:00 amRNSResults of Scrip Dividend Alternative Election
5th Jul 20249:57 amRNSAnnual Financial Report and Financial Statements
21st Jun 20247:00 amRNSAnnual Results for the year ended 31.03.24
1st May 20247:00 amRNSTotal Voting Rights
19th Apr 20242:34 pmRNSDirector/PDMR Shareholding
18th Apr 202411:16 amRNSDirector/PDMR Shareholding
16th Apr 202412:35 pmRNSDirector/PDMR Shareholding
16th Apr 202412:33 pmRNSDirector/PDMR Shareholding
16th Apr 202412:32 pmRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSResults of Scrip Dividend Alternative Election
8th Mar 20248:52 amRNSSale of H20 Shopping Centre Investment, Madrid
1st Mar 20247:00 amRNSTrading Update and Dividend Announcement
13th Feb 20245:03 pmRNSDirector/PDMR Shareholding
1st Feb 202411:58 amRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSTotal Voting Rights
31st Jan 202410:10 amRNSDirector/PDMR Shareholding
31st Jan 202410:10 amRNSDirector/PDMR Shareholding
31st Jan 202410:08 amRNSDirector/PDMR Shareholding
17th Jan 20247:00 amRNSResults of Scrip Dividend Alternative Election
15th Dec 20231:30 pmRNSHalf-year Report
6th Dec 20232:47 pmRNSDirector/PDMR Shareholding
27th Nov 20231:16 pmRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSHalf-year Report
1st Nov 20237:00 amRNSTotal Voting Rights
31st Oct 20236:00 pmRNSDirector/PDMR Shareholding
31st Oct 20235:55 pmRNSDirector/PDMR Shareholding
31st Oct 20235:52 pmRNSDirector/PDMR Shareholding
25th Oct 20239:02 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.